Xenon Pharmaceuticals Stock Price Down 7.3 percent Whats Next?
XENE Stock | USD 39.45 3.52 8.19% |
About 55% of Xenon Pharmaceuticals' investor base is interested to short. The analysis of the overall investor sentiment regarding Xenon Pharmaceuticals suggests that many traders are impartial. The current market sentiment, together with Xenon Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Xenon Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
Xenon |
Xenon Pharmaceuticals Inc. s share price traded down 7.3 percent on Thursday . The stock traded as low as .80 and last traded at .83. 258,167 shares traded hands during trading, a decline of 33 percent from the average session volume of 386,928 shares. The stock had previously closed at 42.97. Analyst Upgrades
Read at thelincolnianonline.com
Xenon Pharmaceuticals Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Xenon Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Xenon Pharmaceuticals Fundamental Analysis
We analyze Xenon Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Xenon Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Xenon Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Per Share
Cash Per Share Comparative Analysis
Xenon Pharmaceuticals is currently under evaluation in cash per share category among its peers. Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Xenon Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Xenon Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Xenon Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Xenon Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Xenon Pharmaceuticals Related Equities
PCVX | Vaxcyte | 0.69 | ||||
UTHR | United Therapeutics | 0.15 | ||||
CYTK | Cytokinetics | 0.91 | ||||
KRON | Kronos Bio | 1.96 | ||||
MGTX | MeiraGTx Holdings | 2.28 | ||||
INBX | Inhibrx | 2.45 | ||||
ASND | Ascendis Pharma | 2.71 | ||||
REPL | Replimune | 3.32 | ||||
MRUS | Merus BV | 4.03 | ||||
ACLX | Arcellx | 4.09 | ||||
IDYA | Ideaya Biosciences | 5.19 | ||||
VRDN | Viridian Therapeutics | 5.22 | ||||
EWTX | Edgewise Therapeutics | 5.54 | ||||
VTYX | Ventyx Biosciences | 6.51 | ||||
DYN | Dyne Therapeutics | 6.77 | ||||
NUVL | Nuvalent | 7.25 | ||||
CRNX | Crinetics Pharmaceuticals | 7.53 | ||||
LYEL | Lyell Immunopharma | 10.59 | ||||
ANAB | AnaptysBio | 32.83 | ||||
KROS | Keros Therapeutics | 73.15 |
Complementary Tools for Xenon Stock analysis
When running Xenon Pharmaceuticals' price analysis, check to measure Xenon Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xenon Pharmaceuticals is operating at the current time. Most of Xenon Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Xenon Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xenon Pharmaceuticals' price. Additionally, you may evaluate how the addition of Xenon Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |